Pure Global
NCT06421844

A Prospective Study: Smart Phone Application for Measure Serum Bilirubin Through Sclera Images

A Prospective Study: A Computer Vision Model on a Smartphone Platform for Real-time Evaluation of Serum Bilirubin Through Sclera Images
Air Force Military Medical University, China·ClinicalTrials.govRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Jaundice,Deep Learning,Hyperbilirubinemia,Sclera
Study type
Observational
Sponsor & location
Primary sponsor
Air Force Military Medical University, China
Location
Xi'an, China
Timeline & enrollment
Phase
N/A
Start date
Apr 20, 2024
End date
Jul 10, 2024
Enrollment
270 participants
Primary outcome

Loss of predicted bilirubin levels,Classification accuracy

Summary

The primary efficacy endpoints are the standard deviation and coefficient of determination
 (R2) between predicted and actual values for the bilirubin regression model, and the grading
 accuracy for the jaundice severity classification model. The secondary efficacy endpoint is
 the mean percentage error between predicted and actual bilirubin values. There are no
 relevant safety risks.
 
 Statistical differences for categorical variables (e.g., jaundice grading evaluation
 indicators) will be analyzed using the chi-square test or Fisher's exact probability test.
 For continuous variables (e.g., bilirubin prediction evaluation indicators), t-tests (normal
 distribution) or non-parametric tests (non-normal distribution) will be used. The 95%
 confidence interval for jaundice grading accuracy will be calculated using the Wilson method.
 
 The study duration is estimated to be 3 months.

ICD-10 classifications
Hyperbilirubinaemia with mention of jaundice, not elsewhere classifiedHyperbilirubinaemia, with or without jaundice, not elsewhere classifiedHyperbilirubinaemia without mention of jaundice, not elsewhere classifiedNeonatal jaundice, unspecifiedNeonatal jaundice from other specified causes
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06421844
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06421844 through Pure Global AI's free database. This phase not specified trial is sponsored by Air Force Military Medical University, China and is currently Recruiting. The study focuses on Jaundice,Deep Learning,Hyperbilirubinemia,Sclera. Target enrollment is 270 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.